RCK Overview
RCK breeds repeatable and stable hybrid cannabis seeds for both the medical and recreational markets. RCK seeks to usher in a new era of cannabis agriculture through methodological, marker-assisted cannabis breeding and the use of proprietary technologies. The company is licensed for the entire production chain, including growing, processing, and distribution, as well as for R&D. Its facilities include an indoor growing room for R&D, a supportive laboratory, and a specially designed greenhouse for breeding and cultivation. RCK is a collaboration between Ruhama, an agriculture-based kibbutz; Canomix, a cannabis genetics R&D company; and Katif, a professional laboratory.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Israeli cannabis genetic startup RCK signs multi-million dollar deal with Holland's SeedTech
Israeli Agtech startup RCK has signed an agreement with SeedTech, a Dutch seed company, for developing unique cannabis strains. The agreement is valued at several million dollars and aims to enable global mass production of medical cannabis and the development of new medications. RCK will receive royalties from the sale of seeds over the duration of the patent life of each strain. RCK has focused on cracking the genetic makeup of the cannabis plant and controlling its chemical compounds to breed new strains suitable for medical and commercial needs. SeedTech, a pioneer in the European cannabis sector, will use advanced technological methods for breeding to develop new cannabis strains for specific market segments.
Partners
growth-positive
Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers
Cannabics Pharmaceuticals has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastrointestinal cancers. RCKMC is an Israeli company focused on breeding stable cannabis hybrid-seeds and genetic research. The collaboration aims to develop cannabis strains with antitumor properties for the development of botanically derived active pharmaceutical ingredients. Cannabics Pharmaceuticals will leverage RCKMCs expertise in plant genetics and breeding to create proprietary drugs from seed to formulation. The partnership is expected to contribute to the growth of Cannabics Pharmaceuticals in the field of personalized cannabinoid medicine for cancer treatment.
Partners
growth-positive
Kibbutz-Based Cannabis Outfit Seeks to Merge With Tel Aviv Shelf Company
Israel-based financial services firm Apex Issuances Ltd. is merging a Kibbutz-based cannabis outfit with a shelf company it controls, Tamda Ltd. Apex has signed a memorandum of understanding with RCKMC Ltd., a cannabis genetic research and nursery company based in Ruhama, a kibbutz in Israel’s south.
AcquisitionPartners
growth-positive
NRGene and RCK to Develop DNA Tests for Medical Cannabis
RCK, a licensed cannabis cultivation company in Israel, has partnered with NRGene, a genome analysis company, to develop a set of DNA markers for strain identification of medical cannabis plants. The partnership aims to ensure the quality and efficacy of medical cannabis by providing reliable authentication of strains. The global use of medical cannabis is expanding rapidly, and the volume of global medical cannabis grown is expected to increase by more than 21% between 2017 and 2024. This partnership addresses the need for accurate strain identification in the growing medical cannabis industry.
Partners
